Loan Agreement under which Parkview agreed to extend a $50 million revolving credit facility maturing April 21, 2031, bearing 12% interest
| Officer | In this role | 2025 pay | Source |
|---|---|---|---|
|
James Bianco
Also a director
Chief Executive Officer
|
Since 2021
5 years
|
$3,987,095 | |
|
Dan Dearborn
Chief Financial Officer
|
Not stated | $1,832,036 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Loan Agreement under which Parkview agreed to extend a $50 million revolving credit facility maturing April 21, 2031, bearing 12% interest
Fee Letter providing a one-time commitment fee of $5 million paid by issuing 1,878,287 shares of common stock, subject to stockholder approval
Royalty Agreement granting Parkview an annual royalty on Net Sales of IFx-2.0 based products
Warrant Amendment Agreements extending the exercise period of 4,364,873 warrants held by K&V Investment to April 21, 2031
Consulting Agreement for as-requested consulting services at an hourly fee of $1,250 plus expenses; no fees paid or accrued through April 30, 2026
December 2025 Securities Purchase Agreement and Side Letter for purchase of shares and Series A and Series B warrants at $1.95 per share in three closings
Secured promissory note and loan agreement with loans up to $3.0 million, later amended to add warrants; loans repaid December 12, 2025
June 2025 offering in which Deferral Investors deferred purchase of a final tranche of shares and warrants, paid by December 31, 2025
Final Purchase Agreements under which Deferral Investors bought $3.2 million of the final tranche in exchange for extending expiration of 2024 Warrants to December 31, 2030
Participation in Legacy TuHURA convertible note private placement via a $10.0 million subscription, converted into shares at the Kintara Merger, with a related warrant
Indemnification agreements with each director and executive officer covering liabilities arising from their service and advancement of expenses
Loading...